These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 39037523)

  • 1. The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: HIPEC Technologies.
    Van der Speeten K; Kusamura S; Villeneuve L; Piso P; Verwaal VJ; González-Moreno S; Glehen O
    Ann Surg Oncol; 2024 Oct; 31(10):7090-7110. PubMed ID: 39037523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: Epithelial Ovarian Cancer.
    Bhatt A; Glehen O; Zivanovic O; Brennan D; Nadeau C; Van Driel W; Bakrin N
    Ann Surg Oncol; 2023 Dec; 30(13):8115-8137. PubMed ID: 37561343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: Pseudomyxoma Peritonei.
    Kusamura S; Delhorme JB; Taibi A; Villeneuve L; Deraco M; Dico RL; Glehen O; Moran B
    Ann Surg Oncol; 2024 Sep; 31(9):6262-6273. PubMed ID: 39008204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2022 Peritoneal Surface Oncology Group International Consensus on HIPEC Regimens for Peritoneal Malignancies: Colorectal Cancer.
    Hübner M; van Der Speeten K; Govaerts K; de Hingh I; Villeneuve L; Kusamura S; Glehen O
    Ann Surg Oncol; 2024 Jan; 31(1):567-576. PubMed ID: 37940803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2022 PSOGI Consensus on HIPEC Regimens for Peritoneal Malignancies: Diffuse Malignant Peritoneal Mesothelioma.
    Kepenekian V; Sgarbura O; Marchal F; Villeneuve L; Kusamura S; Deraco M
    Ann Surg Oncol; 2023 Nov; 30(12):7803-7813. PubMed ID: 37481492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: Methodology.
    Kusamura S; Bhatt A; Hubner M; Villeneuve L; Deraco M; Bakrin N; Van Der Speeten K; Glehen O
    Ann Surg Oncol; 2023 Apr; 30(4):2508-2519. PubMed ID: 36595113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI).
    Bushati M; Rovers KP; Sommariva A; Sugarbaker PH; Morris DL; Yonemura Y; Quadros CA; Somashekhar SP; Ceelen W; Dubé P; Li Y; Verwaal VJ; Glehen O; Piso P; Spiliotis J; Teo MCC; González-Moreno S; Cashin PH; Lehmann K; Deraco M; Moran B; de Hingh IHJT
    Eur J Surg Oncol; 2018 Dec; 44(12):1942-1948. PubMed ID: 30075978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for gastric cancer with peritoneal metastasis: a systematic review].
    Ji CH; Zhou LL; Yang YB; Hu JQ; Wei HR; Dong FH; Shan YQ; Kong WC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Jul; 27(7):740-748. PubMed ID: 39004991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
    Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
    [No Abstract]   [Full Text] [Related]  

  • 10. Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy.
    Ubink I; Bolhaqueiro ACF; Elias SG; Raats DAE; Constantinides A; Peters NA; Wassenaar ECE; de Hingh IHJT; Rovers KP; van Grevenstein WMU; Laclé MM; Kops GJPL; Borel Rinkes IHM; Kranenburg O
    Br J Surg; 2019 Sep; 106(10):1404-1414. PubMed ID: 31197820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Nodes of Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Among Colorectal Cancer Patients: A Swiss National Multicenter Survey.
    Steffen T; Putora PM; Hübner M; Gloor B; Lehmann K; Kettelhack C; Adamina M; Peterli R; Schmidt J; Ris F; Glatzer M
    Clin Colorectal Cancer; 2019 Dec; 18(4):e335-e342. PubMed ID: 31371166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: A web-based survey and 2021 statement by Peritoneal Surface Oncology Group International (PSOGI).
    van de Vlasakker VCJ; Lurvink RJ; Cashin PH; Ceelen W; Deraco M; Goéré D; González-Moreno S; Lehmann K; Li Y; Moran B; Morris DL; Piso P; Quadros CA; Rau B; Somashekhar SP; Sommariva A; van der Speeten K; Spiliotis J; Sugarbaker PH; Teo MCC; Verwaal VJ; Yonemura Y; Glehen O; de Hingh IHJT
    Eur J Surg Oncol; 2021 Nov; 47(11):2888-2892. PubMed ID: 34020808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Construction and evaluation of a nomogram for predicting the prognosis of patients with colorectal cancer with peritoneal carcinomatosis treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
    An SL; Ji ZH; Li XB; Liu G; Zhang YB; Gao C; Zhang K; Zhang XJ; Yan GJ; Yan LJ; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):434-441. PubMed ID: 37217351
    [No Abstract]   [Full Text] [Related]  

  • 14. Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced Recovery After Surgery (ERAS®) Society Recommendations - Part II: Postoperative management and special considerations.
    Hübner M; Kusamura S; Villeneuve L; Al-Niaimi A; Alyami M; Balonov K; Bell J; Bristow R; Guiral DC; Fagotti A; Falcão LFR; Glehen O; Lambert L; Mack L; Muenster T; Piso P; Pocard M; Rau B; Sgarbura O; Somashekhar SP; Wadhwa A; Altman A; Fawcett W; Veerapong J; Nelson G
    Eur J Surg Oncol; 2020 Dec; 46(12):2311-2323. PubMed ID: 32826114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for endometrial cancer-derived peritoneal metastases: a systematic review.
    Tempfer CB; Kern P; Dogan A; Hilal Z; Rezniczek GA
    Clin Exp Metastasis; 2019 Aug; 36(4):321-329. PubMed ID: 31089843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International Expert Consensus on Defining Textbook Oncologic Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastasis.
    Zohar N; Nevler A; Esquivel J; Yeo CJ; Benvenisti H; Elbaz N; Assaf D; Mor E; Bowne WB;
    J Am Coll Surg; 2024 Apr; 238(4):387-401. PubMed ID: 38149780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Laparoscopy in Patients With Peritoneal Carcinomatosis Is Safe and Does Not Delay Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy.
    Hanna DN; Ghani MO; Hermina A; Mina A; Bailey CE; Idrees K; Magge D
    Am Surg; 2022 Apr; 88(4):698-703. PubMed ID: 34732056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced recovery after surgery (ERAS®) Society Recommendations - Part I: Preoperative and intraoperative management.
    Hübner M; Kusamura S; Villeneuve L; Al-Niaimi A; Alyami M; Balonov K; Bell J; Bristow R; Guiral DC; Fagotti A; Falcão LFR; Glehen O; Lambert L; Mack L; Muenster T; Piso P; Pocard M; Rau B; Sgarbura O; Somashekhar SP; Wadhwa A; Altman A; Fawcett W; Veerapong J; Nelson G
    Eur J Surg Oncol; 2020 Dec; 46(12):2292-2310. PubMed ID: 32873454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) vs CRS alone for treatment of endometrial cancer with peritoneal metastases: a multi-institutional study from PSOGI and BIG RENAPE groups.
    Gomes David M; Bakrin N; Salleron J; Kaminsky MC; Bereder JM; Tuech JJ; Lehmann K; Mehta S; Glehen O; Marchal F
    BMC Surg; 2022 Jan; 22(1):1. PubMed ID: 34996419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An International Registry of Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Mercier F; Passot G; Bonnot PE; Cashin P; Ceelen W; Decullier E; Villeneuve L; Walter T; Levine EA; Glehen O; ;
    World J Surg; 2022 Jun; 46(6):1336-1343. PubMed ID: 35286418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.